Advertisement

Annals of Ophthalmology

, Volume 38, Issue 4, pp 311–316 | Cite as

Clinical evaluation of blue-light blocker foldable acrylic IOL (HMY)

  • Tsuyoshi HibinoEmail author
  • Yoshikazu Shimomura
  • Chota Matsumoto
  • Masahiko Fukuda
  • Naoki Uno
  • Masahiko Usui
  • Masaru Takeuchi
  • Tetsuya Asatani
  • Hiroshi Minoda
Original Article
  • 10 Downloads

Abstract

Efficacy and safety of blue-light-filtering acrylic IOL (HMY) were assessed and proven from 3 months to 1 year of postoperative follow-up in a clinical study performed on 80 eyes of 45 patients. Postoperative corrected visual acuity of all the eyes was 6/12 or better and 78.8% of them achieved higher than 6/6. The rate of mean corneal endothelial cell density decrease stood at 5.0%. Mild complciations were observed, but none were serious.

Keywords

Visual Acuity Anterior Chamber Color Vision Intraocular Lens Subconjunctival Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Leaming DV. Practice styles and preferences of ASCRS members—2003 survey. J Cataract Refract Surg. 2004;30:892–900.PubMedCrossRefGoogle Scholar
  2. 2.
    Oshika T, Suzuki Y, Kizaki H, et al. Two year clinical study of a soft acrylic intraocular lens. J Cataract Refract Surg. 1996;22: 104–109.PubMedGoogle Scholar
  3. 3.
    Niwa K, Yoshino Y, Okuyama F, et al. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt. 1996;16: 297–302.PubMedCrossRefGoogle Scholar
  4. 4.
    Yuan Z, Reinach P, Yuan J. Contrast sensitivity and color vision with a yellow intraocular lens. Am J Ophthalmol. 2004;138: 138–140.PubMedCrossRefGoogle Scholar
  5. 5.
    Miyake K, Ichihashi S, Shibuya Y, et al. Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia. J Cataract Refract Surg. 1999;25:891–897.PubMedCrossRefGoogle Scholar
  6. 6.
    Sparrow JR, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg. 2004;30:873–878.PubMedCrossRefGoogle Scholar
  7. 7.
    Neuhann TH, Weber S. Clinical 12-month outcome with the foldable, hydrophobic acrylic lens AMO AR40NB. Klin Monatsbl Augenheilkd. 1999;215:329–333.PubMedCrossRefGoogle Scholar
  8. 8.
    Prosdocimo G, Tassinari G, Sala M, et al. Posterior capsule opacification after phacoemulsification: silicone CeeOn Edge versus acrylate AcrySof intraocular lens. J Cataract Refract Surg. 2003;29:1551–1555.PubMedCrossRefGoogle Scholar
  9. 9.
    Miyata A, Uchida N, Nakajima K, et al. Clinical and experimental observation of glistening in acrylic intraocular lenses. Jpn J Opthalmol. 2001;45:564–569.CrossRefGoogle Scholar
  10. 10.
    Ishida M, Yanashima K, Miwa M, et al. Influence of the yellowtinted intraocular lens on spectral sensitivity. [Japanese] Nippon Ganka Gakkai Zasshi. 1994;98:192–196.PubMedGoogle Scholar

Copyright information

© ASCO 2006

Authors and Affiliations

  • Tsuyoshi Hibino
    • 1
    • 2
    Email author
  • Yoshikazu Shimomura
    • 1
  • Chota Matsumoto
    • 1
  • Masahiko Fukuda
    • 1
  • Naoki Uno
    • 1
  • Masahiko Usui
    • 2
  • Masaru Takeuchi
    • 2
  • Tetsuya Asatani
    • 2
  • Hiroshi Minoda
    • 2
  1. 1.Department of OphthalmologyKinki University School of MedicineOsaka-SaymaJapan
  2. 2.Department of OphthalmologyTokyo Medical University HospitalTokyoJapan

Personalised recommendations